Bárbara Marques

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Joëlle Vermeulen, Katleen De Preter, Arlene Naranjo et al. · The Lancet Oncology · 2009 · 194 citations · Full text

Neuro-oncology, Pediatric Brain Tumors, Pediatric Neurosurgery +8

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

Gudrun Schleiermacher, Jean Michon, Agnès Ribeiro et al. · British Journal of Cancer · 2011 · 98 citations · Full text

ArrayCGH‐based classification of neuroblastoma into genomic subgroups

Evi Michels, Jo Vandesompele, Katleen De Preter et al. · Genes Chromosomes and Cancer · 2007 · 77 citations

Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard et al. · Journal of Clinical Oncology · 2021 · 73 citations · Full text

Small GTPase Rac1: Structure, Localization, and Expression of the Human Gene

Paulo Matos, Jennifer Skaug, Bárbara Marques et al. · Biochemical and Biophysical Research Communications · 2000 · 69 citations

Protein Function, Signal Transduction, Molecular Regulation +10